Switch View
© BusinessWire
19.08.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology Initiates Patent Infringement Ligitation Against Angelalign Technology
News Preview
Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the filing of patent infringement lawsuits against Angel...
Themefolio
Profiler
Peergroup
© Newsfile
18.08.2025
ISIN: CA57384M1077
Marvel Biosciences Corp.
MRVL
LISTED
TSX
Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204
News Preview
Calgary, Alberta--(Newsfile Corp. - August 18, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively "Marvel" or the "Company"), a drug discovery company developing novel therapeutics for autism spectrum disorder and related conditions, today announced that the China...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: CA82621K1021
Sienna Senior Living Inc
SIA
LISTED
TSX
Sienna Announces Offering of $175 Million of 4.112% Series E Senior Unsecured Debentures and Closing of Previously Announced Acquisition in Greater Toronto Area
News Preview
NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
18.08.2025
ISIN: AU000000OPT2
Opthea Ltd
OPT
LISTED
ASX
Opthea Provides Corporate Update
News Preview
Successful DFA settlement reached...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
18.08.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II
News Preview
RGX-121 would be the first and only potential one-time commercially-available therapy designed to directly address the underlying genetic cause of Hunter syndrome, if approvedCommercial launch plans remain on track REGENXBIO plans to present updated pivotal data during the ICIEM meeting in September 2025ROCKVILLE, Md., Aug. 18, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US09075V1026
Biontech SE
BNTX
LISTED
NASDAQ
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
News Preview
LP.8.1 variant adapted COVID-19 vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks.KIRKLAND, QC, Aug. 18, 2025 /CNW/ - Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 variant a...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. (NUTX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith continues its investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NUTEX HEALTH INC. (NUTX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US58502B1061
Pediatrix Medical Group Inc
MD
LISTED
NYSE
Pediatrix Medical Group Announces $250 Million Share Repurchase Program
News Preview
Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced that its Board of Directors has authorized a share repurchase program of up to $250 million of the Company’s outstanding common stock.
“In view of our strong cash flow, current and forecasted cash balances and relatively low debt levels, our Board...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effe...
Themefolio
Profiler
Peergroup
© EQS Newswire
18.08.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah gibt Finanzergebnisse und operatives Update für das zweite Quartal bekannt
News Preview
Nyxoah gibt Finanzergebnisse und operatives Update für das zweite Quartal bekannt
FDA genehmigt Genio®-System für den US-Markt; Unternehmen beginnt mit der kommerziellen Markteinführung
Mont-Saint-Guibert, Belgien – 18. August 2025, 22:10 Uhr MESZ – Nyxoah SA (Euronext Brüssel/Nasdaq: NYXH) („Nyxoah” oder das „Unternehmen”), ein Medizintechnikun......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.08.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Reports Second Quarter Financial and Operating Results
News Preview
Nyxoah Reports Second Quarter Financial and Operating Results
FDA Approves Genio® System for U.S. Market; Company Begins Commercial Launch
Mont-Saint-Guibert, Belgium – August 18, 2025, 10:10pm CET / 4:10 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatm......
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US30050B1017
Evolent Health Inc
EVH
LISTED
NYSE
Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
News Preview
WASHINGTON, Aug. 18, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced that it intends to offer $140.0 million aggregate principal amount of convertible senior notes due 2031, subject to market and other conditions. Evolent a...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
18.08.2025
ISIN: US01988P1084
Veradigm Inc
MDRX
LISTED
OTC
Veradigm Appoints Don Trigg as Chief Executive Officer
News Preview
Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that its Board of Directors has appointed Don Trigg, an industry leader with over two decades of healthcare technology experience, as the Company’s new Chief Executive Officer and member of the Board, effective as of September 2, 2025.
Trig...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US3741631036
Geron Corp
GERN
LISTED
NASDAQ
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of 522,000 shares of its common stock, consisting of stock options to purchase an aggregate of 348,000 shares of common stock, and restricted stock units (“RSUs”) representing an aggregate of 174,00...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
News Preview
WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi, has donated 10,000 of his personal shares of common stock to the Warren Township Honorary Policemen’s Benevolent Association (P.B.A.) Local 235....
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery
News Preview
WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that Founder and CEO of Tevogen, Dr. Ryan Saadi, donated 10,000 of his personal shares of common stock to the Opportunity Project, a Millburn, N.J.–based nonprofit dedicated to empowering individuals with brain injuri...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Securities Fraud Investigation Into Nutex Health Inc. (NUTX) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz continues its investigation of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US9290331084
Vor Biopharma Inc.
VOR
LISTED
NASDAQ
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, between August 4, 2025, and August 18, 2025, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 6,959,013 sha...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US00534A1025
Invivyd Inc
IVVD
LISTED
NASDAQ
Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)
News Preview
WALTHAM, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA® (pemivibart) against the currently dominant and growing XFG variant of SARS-CoV-2. Notably, and consistent with all dominant variants for the past three years, XFG did...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US2697961082
Eagle Pharmaceuticals Inc
EGRX
LISTED
NASDAQ
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
News Preview
WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) will be held on October 17, 2025. The specific time and place for the 2025 Annual Meeting will be specified in a notice and meeting...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US7402944000
Precision Optics Corp, Inc.
POCI
LISTED
NASDAQ
Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
News Preview
GARDNER, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it will participate in a webcast presentation at the Lytham Partners 2025 Consumer & Tec...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US7611521078
Resmed Inc
RMD
LISTED
NYSE
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
News Preview
SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15, 2025. The company also announced that board member Rich Sulpizio is thanked for two decades of contributions to Resmed, and will retire from the board, not standing for reele...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Unicycive Therapeutics, Inc. (“Unicycive” or “the Company”) (NASDAQ: UNCY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commi...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Reports Second Quarter Financial and Operating Results
News Preview
REGULATED INFORMATION...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US8087571084
Scientific Industries, Inc.
SCND
LISTED
OTC
Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025
News Preview
Investor Call to be held at 11:00 AM Eastern Time Investor Call to be held at 11:00 AM Eastern Time...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US68622P1093
Oric Pharmaceuticals Inc
ORIC
LISTED
NASDAQ
ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer
News Preview
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the appointment of Kevin Brodbeck, PhD, to the newly established role of Chief Technical Offic...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US03589W1027
Annexon Inc
ANNX
LISTED
NASDAQ
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BRISBANE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that it has granted inducement to a new n...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US45107K1025
iBio Inc
IBIO
LISTED
NASDAQ
iBio Announces Proposed Public Offering
News Preview
SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced it has commenced an underwritten public offering (the “offering”) of (i) pre-funded warrants to purchase shares of iBio’s common stock, and (ii) accompanying Series G warrants each representing the right...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
WATERTOWN, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outsid...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) and reminds investors of the October 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US66737P6007
Northwest Biotherapeutics Inc
NWBO
LISTED
OTC
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman
News Preview
BETHESDA, Md., Aug. 18, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced with deep sadness the passing of its Senior Vice President and General Counsel, Mr. Les Goldman, due to a stroke.
The Company...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US66737P6007
Northwest Biotherapeutics Inc
NWBO
LISTED
OTC
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman
News Preview
BETHESDA, Md., Aug. 18, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced with deep sadness the passing of its Senior Vice President and General Counsel, Mr. Les Goldman, due to a stroke. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US59064R1095
Mesa Laboratories, Inc
MLAB
LISTED
NASDAQ
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
News Preview
LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company’s 1.375% Convertible Senior Notes due August 2025 (the “2025 Notes”). On Aug...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Centene Corporation (CNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Centene Corporation ("Centene" or the "Company") (NYSE: CNC) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Corporation (NEOG) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
Shareholders with losses of $100,000 or more are encouraged to contact the firm.
LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST)....
Themefolio
Profiler
Peergroup
© EQS Newswire
18.08.2025
ISIN: CH0012627250
HBM Healthcare Investments AG
HBMN
LISTED
SIX
Key Figures
15.08.2025
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.08.2025
18.08.2025 / 17:47 CET/CEST
in CHF
Performance in %
15.08.2025
MTD
FYTD
CYTD
NAV
240.16
3.3
1.3
......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
18.08.2025
ISIN: CA58469E4085
Medicure Inc.
MPH
LISTED
TSX
Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025
News Preview
WINNIPEG, MB / ACCESS Newswire / August 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present Financial Results for the quarter ended...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: US2214133058
Cosmos Health Inc
COSM
LISTED
NASDAQ
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
News Preview
Cosmos Health reported Q2 2025 results with 11.7% revenue growth and H1 gross profit up 53% to $3.21M, remaining on track with profitability targets...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Centene Corporation Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds CNC Investors of Important Lead Plaintiff Deadline on September 8, 2025
News Preview
RADNOR, Pa., Aug. 18, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Centene Corporation ("Centene") (NYSE: CNC) on behalf of those who purchased or otherwise acquired Centene securities between December 12, 2024, and June 3...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.08.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares - July 2025
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Alto Neuroscience, Inc. (NYSE: ANRO) between Feb. and Oct. 2024 should contact the Shareholders Foundation
News Preview
SAN DIEGO, Aug. 18, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a deadline is coming up in the lawsuit for certain investors in shares of Alto Neuroscience, Inc. (NYSE: ANRO).
Investors who purchased in ex...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US71715X2036
PharmaCyte Biotech, Inc.
PMCB
LISTED
NASDAQ
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
News Preview
PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”) announced today that it has entered into a securities purchase agreement for a $7.0 million financing with existing investors involving the sale of 7,000 shares of its newly designated Series C convertible preferred stock ("preferred stock"), with a stated value of $1,000 per s...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
News Preview
Global partnerships to help customers improve clinical and commercial efficiency and effectiveness
RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif., Aug. 18, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
News Preview
Global partnerships to help customers improve clinical and commercial efficiency and effectiveness
RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif., Aug. 18, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
IQVIA und Veeva geben langfristige klinische und kommerzielle Partnerschaften sowie die Beilegung aller strittigen Fragen bekannt
News Preview
Globale Partnerschaften zur Unterstützung der Kunden bei der Verbesserung der klinischen und kommerziellen Effizienz und Effektivität
RESEARCH TRIANGLE PARK, North Carolina, und PLEASANTON, Kalifornien, USA, 18. August 2025 /PRNewswire/ -- IQVIA (NYSE: IQV) und Veeva Systems (NYSE: VEEV) gaben heute globale klinische und kommerzielle Partnerschaf...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US0028241000
Abbott Laboratories
ABT
LISTED
NYSE
Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season
News Preview
All 18 Big Ten universities will go head-to-head in Year 2 of the nationwide challenge, the 'We Give Blood' drive, to inspire the most blood donations from students, alumni, and fans with the winning school earning $1 million from Abbott for student or community healthAbbott is releasing exclusive, limited-edition Homefield designed T-shirts fo...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US0367521038
Elevance Health Inc
ANTM
LISTED
NYSE
Elevance Health and National Association of Community Health Centers Partnership Integrates Food as Medicine With Primary Care
News Preview
Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of Food as Medicine (FAM) programming with primary care Community Health Centers (CHCs). This milestone - built on a shared commitment to whole health and community-centered innovation - marks a transformative step forward in addr...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
News Preview
IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the long-term agreement, customers can use software, data, technology, and service offerings from Veeva and IQVIA together in a simple and efficient way.
This pr...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: GB00BYMT0J19
LivaNova PLC
LIVN
LISTED
NASDAQ
LivaNova Launches Essenz Perfusion System in China
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it initiated the commercial launch of the Essenz™ Perfusion System in China, the second-largest market for LivaNova heart-lung machines (HLMs) after the United States. The Essenz Perfusion System, which recently received regulatory approval from China’s Natio...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 19, 2025 in Alto Neuroscience, Inc. Lawsuit - ANRO
News Preview
NEW YORK, Aug. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO).
Shareholders who purchased shares of ANRO during the class period listed are encouraged...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Centene Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before September 8, 2025 to Discuss Your Rights - CNC
News Preview
NEW YORK, Aug. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Centene Corporation (NYSE: CNC).
Shareholders who purchased shares of CNC during the class period listed are encouraged to co...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - HIMS
News Preview
NEW YORK, Aug. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).
Shareholders who purchased shares of HIMS during the class period listed are encou...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Lost Money on Biohaven Ltd.(BHVN)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
News Preview
NEW YORK, Aug. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd. (NYSE: BHVN).
Shareholders who purchased shares of BHVN during the class period listed are encouraged to contac...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against Alto Neuroscience, Inc. ("Alto Neuroscience" or "the Company") (NYSE: ANRO) for violations of the federal securities laws....
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
ISIN: US74051N1028
Premier Inc
PINC
LISTED
NASDAQ
Premier, Inc. Declares Quarterly Cash Dividend
News Preview
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on September 15, 2025, to stockholders of record as of the close of business on September...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
News Preview
LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Centene Corporation Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - CNC
News Preview
LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to...
Themefolio
Profiler
Peergroup
© Newsfile
18.08.2025
ISIN: CA75671E1097
Red Light Holland Corp.
TRIP
LISTED
CSE
Red Light Holland Receives Initial Third-Party Psilocybin Testing Results via FDA-Compliant, DEA-Registered Partner, Irvine Labs
News Preview
Initial testing results confirm psilocybin potency and process validation for potential medical grade manufacturing applicationsIrvine Labs progresses development of proprietary dehydration and packaging processes while preparing for next scheduled importToronto, Ontario--(Newsfile Corp. - August 18, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE...
Themefolio
Profiler
Peergroup
© PR Newswire
18.08.2025
ISIN: US98986M1036
Zynex Inc
ZYXI
LISTED
NASDAQ
Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles
News Preview
ENGLEWOOD, Colo., Aug. 18, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the arrival of newly appointed CEO, Steven Dyson, and the appointment of several...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
